The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.74

Today's change0.00 0.00%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.74

Today's change0.00 0.00%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc closed at (U.S.)$33.74.

Shares have lost 0.76% over the last five days, but have gained 3.88% over the last year to date. This security has underperformed the S&P 500 by 12.10% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $33.74
  • High--
  • Low--
  • Bid / Ask(U.S.) $33.21 / (U.S.) $34.09
  • YTD % change+3.88%
  • Volume100
  • Average volume (10-day)19,157,388
  • Average volume (1-month)20,426,250
  • Average volume (3-month)23,697,449
  • 52-week range(U.S.) $29.83 to (U.S.) $37.39
  • Beta0.97
  • Trailing P/E28.93×
  • P/E 1 year forward13.24×
  • Forward PEG2.22×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield3.79%
  • Trailing EPS(U.S.) $1.17
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Oct 02, 201610/02/2016Jul 03, 201607/03/2016Apr 03, 201604/03/2016
Revenue13,62813,04513,14713,005
Total other revenue--------
Total revenue13,62813,04513,14713,005
Gross profit10,4149,9639,97310,154
Total cost of revenue3,2143,0823,1742,851
Total operating expense12,70711,33510,5479,234
Selling / general / administrative4,4233,5593,4713,385
Research & development2,5121,8811,7481,731
Depreciation / amortization1,1229689611,006
Interest expense (income), net operating--------
Unusual expense (income)1,4942,1181,453596
Other operating expenses, total-58-273-260-335
Operating income9211,7102,6003,771
Interest income (expense), net non-operating-312-309-308-321
Gain (loss) on sale of assets9047319
Other--------
Income before tax7761,6042,4103,561
Income after tax8471,3202,0353,026
Income tax, total-71284375535
Net income8581,3202,0203,017
Total adjustments to net income1-1-1-1
Net income before extra. items8411,3202,0193,017
Minority interest-60-16-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8421,3192,0183,016
Inc. avail. to common incl. extra. items8591,3192,0193,016
Diluted net income8591,3192,0193,016
Dilution adjustment--000
Diluted weighted average shares6,1446,1386,1376,214
Diluted EPS excluding extraordinary itemsvalue per share0.140.210.330.49
Dividends per sharevalue per share0.300.300.300.30
Diluted normalized EPSvalue per share0.360.540.550.60